Pharmacogenetics of b2-Agonists in Asthma.

• Status: Completed
• Trial end date: 0000-00-00

Summary

This study will help to find out if having a certain genetic makeup influences how a person with asthma responds to salmeterol, one of the two drugs in Advair(R).

• Phase: Phase 4

Details

• Lead Sponsor: Nemours Children's Clinic
• Collaborators: National Heart, Lung, and Blood Institute (NHLBI); University of Florida
• Treatments: Bromides; Fluticasone; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Ipratropium; Salmeterol Xinafoate